Drugs / Hedera Helix Extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06907355 | May → Nov 2025 | respiratory tract infectious disorder | Pontificia Universidad Catolica de Chile | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hedera Helix Extract | “Ivy Leaf (Hedera Helix Extract) 35 mg/5ml: 10ml three times per day during 4 days” NCT06907355 ↗ |
| Known as | Ivy Leaf | “Ivy Leaf (Hedera Helix Extract) 35 mg/5ml: 10ml three times per day during 4 days” NCT06907355 ↗ |